Dr Elizabeth Robertson, Diabetes UK's Director of Research and Clinical, shares her thoughts following the historic approval of the first type 1 diabetes immunotherapy on the NHS.

The National Institute for Health and Care Excellence (NICE) has approved teplizumab for use on the NHS for people with early-stage type 1 diabetes, marking the start of a new era in how we treat the ...

Our new data shows type 2 diabetes is rising twice as fast in women under the age of 40 compared to women over 40. Save for later Page saved! You can go back to this later in your Diabetes and Me ...

Diabetes Scotland have sent an open letter to the Scottish Government requesting they reconsider the decision to withdraw central funding for hybrid closed loop systems for people living with type 1 ...

New research has revealed the scale of stigma experienced by women with gestational diabetes, highlighting the significant toll on their wellbeing.

The way funding for hybrid closed loop technology works in Scotland is changing.

We take a look at some of the exciting diabetes research developments announced in March 2026, and what the findings could mean for people living with or affected by diabetes.

We take a look at some of the exciting diabetes research developments announced in January 2026, and what the findings could mean for people living with or affected by diabetes.

Our landmark ELSA study (Early Surveillance for Autoimmune diabetes) has shown that childhood screening for type 1 diabetes works.

We take a look at some of the exciting diabetes research developments announced in November 2025, and what the findings could mean for people living with or affected by diabetes.

The Driving and Vehicle Licensing Agency (DVLA) will now allow people with diabetes who hold Group 2 licences to use continuous glucose monitoring to monitor their blood glucose levels when driving.

Our researchers have identified a key protein that triggers the earliest stages of diabetic retinopathy.